Method of treating non-streptococcal bacterial infections

Details Method of treating non-streptococcal bacterial infections Method of treating non-streptococcal bacterial infections

1991-11-27

1995-04-11

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, C07K 1528, C12N 512, G01N 3353

Patent

active

054058325

ABSTRACT:
A method of treating non-Streptococcal bacterial infections in a mammal comprising administering to the mammal an effective amount of modified C-reactive protein (CRP) in a pharmaceutically-acceptable carrier. Modified-CRP has been found to be particularly effective in treating gram-negative bacterial infections and endotoxic shock.

REFERENCES:
patent: 5272258 (1993-12-01), Siegel et al.
Ballou et al., J. Lab. Clin. Med., 115, 332-338 (1990).
Barna et al., Cancer Research, 44, 305-310 (1984).
Bray et al., Clin. Immunol. Newsletter, 8, 137-140 (1987).
Chu et al., Proc. Amer. Acad. Cancer Res., 28, 344a (1987).
Chu et al., Proc. Amer. Acad. Cancer Res., 29, 371a (1988).
Chudwin et al., J. Allergy Clin. Immunol., 77, 216a (1986).
Deodhar et al., Cancer Research, 42, 5084-5088 (1982).
Galanos et al., Proc. Natl. Acad. Sci. USA, 76, 5939 (1979).
Gotschlich, Ann. N.Y. Acad. Sci., 557, 9-18 (1989).
Gupta et al., J. Immunol., 137, 2173-2179 (1986).
Hokama et al., J. Bacteriology, 83, 1017-1024 (1962).
Horowitz et al., J. Immunol., 138, 2598-2603 (1987).
Hu et al., J. Biol. Chem., 263, 1500-1504 (1988).
Hu et al., Biochem., 25, 7834-7839 (1986).
James et al., Dissertation Abstracts International, 41/08-B, 2963 (1980).
Kempka et al., J. Immunol., 144, 1004-1009 (1990).
Kilpatrick and Volanakis, Immunol. Res., 10, 43-53 (1991).
Kilpatrick and Volanakis, J. Immunol., 134, 3364-3370 (1985).
Kindmark, Clin. Exp. Immunol., 8, 941-948 (1971).
Lei et al., J. Biol. Chem., 260, 13377-13383 (1985).
Mantzouranis et al., Ped. Res., 18, 260a (1984).
Mitzner et al., Artificial Organ, 15, 338 (1991).
Mold et al., Ann. N.Y. Acad. Sci., 389, 251-262 (1982).
Mold et al., Infection and Immunity, 38, 392-395 (1982).
Nagaki et al., Artificial Organ, 15, 338 (1991).
Nakayama et al., Clin. Exp. Immunol., 54, 319-326 (1983).
Nakayama et al., J. Immunol., 132, 1336-1340 (1984).
Nanbu et al., Artificial Organ, 15, 290 (1991).
Noronha-Blob et al., Eur. J. Pharmacol., 199, 387-388 (1991).
Potempa et al., Protides Biol. Fluids, 34, 287-290 (1986).
Potempa et al., Mol. Immunol., 24, 531-541 (1987).
Potempa et al., Inflammation, 12, 391-405 (1988).
Potempa et al., Mol. Immunol., 20, 1165-1175 (1983).
Potempa et al., FASEB J., 2, 731a (1988).
Potempa et al., Proc. Amer. Acad. Cancer Res., 28, 344a (1987).
Rees et al., Fed. Proc., 45, 263a (1986).
Samols et al., Biochem. J., 227, 759-765 (1985).
Samola and Hu, Protides Biol. Fluids, 34, 263-266 (1986).
Tebo et al., J. Immunol., 144, 231-238 (1990).
Teng et al., Proc. Natl. Acad. Sci. USA, 82, 1790-1794 (1985).
Thombre et al., Cancer Immunol. Immunother., 16, 145-150 (1984).
Tillett and Francis, J. Exp. Med., 52, 561-571 (1930).
Volanakis, et al., J. Immunol., 113, 9-17 (1974).
Whitehead et al., Biochem. J., 266, 283-290 (1990).
Woo et al., J. Biol. Chem., 260, 13384-13388 (1985).
Xia et al., FASEB J., 5, A1628 (1991).
Ying et al., J. Immunol., 143, 221-228 (1989).
Zeller et al., Fed. Proc., 46, 1033a (1987).
Ziegler et al., New Eng. J. Med., 324, 429-435 (1991).
Ziegler et al., Clin. Res., 35, 619A (1987).
Bacterial Endotoxic Lipopolysaccharides, vol. II, Immunopharmacology as Pathophysiology, ed by J. L. Ryan ad D. C. Morrison, CRC Press, Boca Raton.
F. B. Taylor, Jr., Baboon Model of E. Coli Seplsis: Summary . . . Marbers, #42, Collogiom, Mosbach '91 Molecular Aspects of Inflammation, Springer-Verlag, Berlin, 1991.
Ammar et al. J. Clin. Invest., 87(6) 2048-2055 Biological and Biochemical . . . normal T Cells.
Rudd et al, PNAS, 85 pp. 5190-5194 Jul. '88, The C04 Receptor . . . T lymphocytes.

Affiliated with

Also associated with

Rating

Method of treating non-streptococcal bacterial infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating non-streptococcal bacterial infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating non-streptococcal bacterial infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1538553